CN104736540B - 培美曲塞及其赖氨酸盐的制备方法 - Google Patents

培美曲塞及其赖氨酸盐的制备方法 Download PDF

Info

Publication number
CN104736540B
CN104736540B CN201380041935.8A CN201380041935A CN104736540B CN 104736540 B CN104736540 B CN 104736540B CN 201380041935 A CN201380041935 A CN 201380041935A CN 104736540 B CN104736540 B CN 104736540B
Authority
CN
China
Prior art keywords
pemetrexed
salt
water
lysine
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380041935.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN104736540A (zh
Inventor
F·博纳科尔西
F·卡尔瓦尼
F·帕斯奎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlin Chemie AG
Original Assignee
Berlin Chemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie AG filed Critical Berlin Chemie AG
Publication of CN104736540A publication Critical patent/CN104736540A/zh
Application granted granted Critical
Publication of CN104736540B publication Critical patent/CN104736540B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201380041935.8A 2012-08-08 2013-08-08 培美曲塞及其赖氨酸盐的制备方法 Active CN104736540B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2012A000398 2012-08-08
IT000398A ITRM20120398A1 (it) 2012-08-08 2012-08-08 Procedimento di sintesi pemetrexed e suo sale di lisina.
PCT/IB2013/056497 WO2014024164A1 (en) 2012-08-08 2013-08-08 Process for the preparation of pemetrexed and lysin salt thereof

Publications (2)

Publication Number Publication Date
CN104736540A CN104736540A (zh) 2015-06-24
CN104736540B true CN104736540B (zh) 2017-08-25

Family

ID=47018368

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380041935.8A Active CN104736540B (zh) 2012-08-08 2013-08-08 培美曲塞及其赖氨酸盐的制备方法

Country Status (23)

Country Link
EP (1) EP2882753B1 (cg-RX-API-DMAC10.html)
KR (1) KR102288417B1 (cg-RX-API-DMAC10.html)
CN (1) CN104736540B (cg-RX-API-DMAC10.html)
AU (1) AU2013301156B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015002429A8 (cg-RX-API-DMAC10.html)
CY (1) CY1118514T1 (cg-RX-API-DMAC10.html)
DK (1) DK2882753T3 (cg-RX-API-DMAC10.html)
ES (1) ES2607890T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20170011T1 (cg-RX-API-DMAC10.html)
HU (1) HUE032304T2 (cg-RX-API-DMAC10.html)
IN (1) IN2015DN00833A (cg-RX-API-DMAC10.html)
IT (1) ITRM20120398A1 (cg-RX-API-DMAC10.html)
LT (1) LT2882753T (cg-RX-API-DMAC10.html)
MX (1) MX362858B (cg-RX-API-DMAC10.html)
PL (1) PL2882753T3 (cg-RX-API-DMAC10.html)
PT (1) PT2882753T (cg-RX-API-DMAC10.html)
RS (1) RS55515B1 (cg-RX-API-DMAC10.html)
RU (1) RU2609006C2 (cg-RX-API-DMAC10.html)
SI (1) SI2882753T1 (cg-RX-API-DMAC10.html)
SM (2) SMT201600474T1 (cg-RX-API-DMAC10.html)
TW (1) TWI609017B (cg-RX-API-DMAC10.html)
WO (1) WO2014024164A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201501549B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107641124A (zh) * 2016-07-22 2018-01-30 上海创诺制药有限公司 一种培美曲塞二酸新晶型及其制备方法
CN109836425B (zh) * 2017-11-24 2023-01-24 江苏创诺制药有限公司 一种合成培美酸的制备工艺
JP7490239B2 (ja) 2018-02-07 2024-05-27 エル．イー．エー．エフ． ホールディングス グループ エルエルシー ガンマポリグルタミン酸化ペメトレキセドおよびその使用
JP7491572B2 (ja) 2018-02-07 2024-05-28 エル．イー．エー．エフ． ホールディングス グループ エルエルシー アルファポリグルタミン酸化ペメトレキセドおよびその使用
CN110128428A (zh) * 2018-02-09 2019-08-16 鲁南制药集团股份有限公司 培美曲塞丙氨酸盐
CN110128426B (zh) * 2018-02-09 2021-12-14 鲁南制药集团股份有限公司 培美曲塞谷氨酸盐
CN110128427A (zh) * 2018-02-09 2019-08-16 鲁南制药集团股份有限公司 培美曲塞缬氨酸盐
CN111333658A (zh) * 2020-05-06 2020-06-26 贵州联科中贝制药科技有限公司 一种培美曲塞二钠水合物的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1087910A (zh) * 1992-09-25 1994-06-15 伊莱利利公司 5-取代的吡咯并[2，3-d]嘧啶的制备方法
EP2301909A1 (en) * 2008-05-30 2011-03-30 Shanghai Cdymax Pharmaceuticals Co., Ltd Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal
CN102344452A (zh) * 2010-07-22 2012-02-08 凯米股份公司 合成培美曲塞二钠盐的新方法
WO2012056285A1 (en) * 2010-10-25 2012-05-03 Fresenius Kabi Oncology Ltd. An improved process for the preparation of pemetrexed

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112991A (en) 1988-10-31 1992-05-12 Mitsui Toatsu Chemicals Incorporated Process for the preparation of an organo-substituted sodium aluminum hydride
KR0162654B1 (ko) 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
IL96531A (en) 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
US5416211A (en) 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
DE19725647A1 (de) 1997-06-18 1998-12-24 Basf Ag Cyclopenta[I]phenanthren-Metallkomplex-Katalysatorsysteme
ZA987550B (en) 1997-09-26 2000-02-21 Lilly Co Eli Processes and intermediates useful to make antifolates.
HU229704B1 (en) 2000-02-25 2014-05-28 Lilly Co Eli A novel crystalline form of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process for its preparation
KR101101443B1 (ko) * 2006-08-14 2012-01-03 시코르, 인크. 페메트렉세드의 중간체의 제조 방법
EP1934226A2 (en) * 2006-08-14 2008-06-25 Sicor, Inc. Highly pure pemetrexed diacid and processes for the preparation thereof
EP2598148A4 (en) 2010-07-28 2014-05-28 Eagle Pharmaceuticals Inc PHARMACEUTICAL COMPOSITIONS WITH PEMETREXED WITH EXTENDED STORAGE STABILITY

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1087910A (zh) * 1992-09-25 1994-06-15 伊莱利利公司 5-取代的吡咯并[2，3-d]嘧啶的制备方法
EP2301909A1 (en) * 2008-05-30 2011-03-30 Shanghai Cdymax Pharmaceuticals Co., Ltd Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal
CN102344452A (zh) * 2010-07-22 2012-02-08 凯米股份公司 合成培美曲塞二钠盐的新方法
WO2012056285A1 (en) * 2010-10-25 2012-05-03 Fresenius Kabi Oncology Ltd. An improved process for the preparation of pemetrexed

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A New and Efficient Synthesis of Pyrrolo[2,3-d]pyrimidine Anticancer Agents: Alimta (LY231514, MTA), Homo-Alimta,TNP-351, and Some Aryl 5-Substituted Pyrrolo[2,3-d]pyrimidines;Edward C. Taylor，等;《J. Org. Chem.》;20031122;第68卷(第26期);第9938-9947页 *
A Novel Synthetic Approach to Pyrrolo[2,3-d]pyrimidine Antifolates;Tetauo Miwa，等;《Journal of Organic Chemistry》;19931231;第58卷(第7期);第1696-1701页 *
A Practical Synthesis of Multitargeted Antifolate LY231514;Charles J. Barnett，等;《Organic Process Research & Development》;19990430;第3卷(第3期);第184-188页 *

Also Published As

Publication number Publication date
LT2882753T (lt) 2016-12-12
RU2609006C2 (ru) 2017-01-30
TW201412741A (zh) 2014-04-01
MX362858B (es) 2019-02-20
IN2015DN00833A (cg-RX-API-DMAC10.html) 2015-06-12
KR20150045458A (ko) 2015-04-28
DK2882753T3 (en) 2017-01-16
RS55515B1 (sr) 2017-05-31
SMT201600474B (it) 2017-03-08
EP2882753A1 (en) 2015-06-17
EP2882753B1 (en) 2016-10-05
WO2014024164A1 (en) 2014-02-13
KR102288417B1 (ko) 2021-08-11
SMT201600474T1 (it) 2017-03-08
BR112015002429A2 (pt) 2017-07-04
AU2013301156A1 (en) 2015-02-05
ZA201501549B (en) 2016-01-27
MX2015001712A (es) 2015-08-14
CN104736540A (zh) 2015-06-24
HRP20170011T1 (hr) 2017-03-10
CY1118514T1 (el) 2017-07-12
ES2607890T3 (es) 2017-04-04
TWI609017B (zh) 2017-12-21
AU2013301156B2 (en) 2017-08-31
PL2882753T3 (pl) 2017-04-28
RU2015108042A (ru) 2016-09-27
HUE032304T2 (en) 2017-09-28
PT2882753T (pt) 2016-12-27
SI2882753T1 (sl) 2017-02-28
HK1209426A1 (en) 2016-04-01
BR112015002429A8 (pt) 2019-07-30
ITRM20120398A1 (it) 2014-02-09

Similar Documents

Publication Publication Date Title
CN104736540B (zh) 培美曲塞及其赖氨酸盐的制备方法
CN101679218B (zh) 晶体米诺环素碱及其制备方法
JP2022023891A (ja) オメカムチブメカルビルの塩及び塩を調製するプロセス
CN101535311B (zh) 吡咯并嘧啶酮衍生物的盐及其制备方法
US9073899B2 (en) Solid forms of dabigatran etexilate mesylate and processes for their preparation
KR20190026895A (ko) NaPi-IIb 억제제로서 유용한 축합된 티오펜 유도체
KR101710740B1 (ko) 2-［［［2-［(히드록시아세틸)아미노］-4-피리디닐］메틸］티오］-ｎ-［4-(트리플루오로메톡시)페닐］-3-피리딘카르복사미드의 벤젠술폰산염, 이의 결정, 이의 결정 다형 및 이들의 제조 방법
CN103298825A (zh) 具有所限定粒径的纯的非多晶型的结晶胆汁酸的优化合成
MXPA06014797A (es) Procesos para preparacion de antagonistas de receptor de hormona que libera gonadotropina.
CN109384767B (zh) 一种吡啶并嘧啶类衍生物的制备方法及其中间体
TW201412745A (zh) Ｎ－［２－（｛２－［（２Ｓ）－２－氰基吡咯啶－１－基］－２－側氧乙基｝胺基）－２－甲基丙基］－２－甲基吡唑并［１，５－ａ］嘧啶－６－甲醯胺之結晶
ES2374156T3 (es) Fumarato de 2-(3-(4-(2-t-butil-6-trifluorometilpirimidin-4-il)piperazin-1-il)propilmercapto)pirimidin-4-ol.
WO2019040499A2 (en) ARF6 INHIBITORS AND ASSOCIATED METHODS
CN115073518A (zh) 磷酸双依达拉奉酯类化合物、及其制备方法和用途
HK1209426B (en) Process for the preparation of pemetrexed and lysin salt thereof
WO2021123076A1 (en) Phosphate derivatives of rorgamma modulators and uses thereof
CN113788835B (zh) 一种含吗啉和喹啉环的三唑并四嗪类化合物及其制备方法和应用
CN102341392A (zh) 二氢苯并噁唑-6-基-乙酰胺衍生物的新的结晶水合物、无定形和多晶型形式及其制备方法
HK40099799A (zh) 用於制备双杂芳基化合物及其晶型的方法
CN116283643A (zh) 氯硝柳胺氨基酸酯衍生物或其可药用盐及其制备方法
HK1240593A1 (en) Synthesis of cyclocreatine and analogs thereof
HK1219484B (zh) 心肌肌球蛋白激动剂的盐和制备盐的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant